AII trades 2.1% above Wall Street's consensus target of $26.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes AII achieves its forward estimates and maintains a stable P/E multiple of 6.3x. This scenario reflects the blended consensus of 5 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 6, 2026, American Integrity Insurance Group, Inc. (AII) has a Wall Street consensus price target of $26.50, based on estimates from 5 covering analysts. With the stock currently trading at $27.08, this represents a potential downside of -2.1%. The company has a market capitalization of $531M.
Analyst price targets range from a low of $26.00 to a high of $27.00, representing a 4% spread in expectations. The median target of $26.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 5 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, AII trades at a trailing P/E of 4.8x and forward P/E of 6.3x. Analysts expect EPS to grow -4.3% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $35.36, with bear and bull scenarios of $22.28 and $46.59 respectively. Model confidence stands at 55/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
HCIHCI Group, Inc. | $2.5B | $192.03 | $230.00 | +19.8% | Buy | 9.2x | 14 |
UPCUniverse Pharmaceuticals Inc. | $788673 | $1.40 | — | — | — | — | — |
HRTGHeritage Insurance Holdings, Inc. | $1.0B | $33.69 | $36.50 | +8.3% | Buy | 5.8x | 9 |
ALLThe Allstate Corporation | $68.7B | $266.72 | $266.43 | -0.1% | Hold | 7.4x | 45 |
TRVThe Travelers Companies, Inc. | $84.0B | $402.89 | $356.18 | -11.6% | Hold | 11.0x | 44 |
CBChubb Limited | $144.1B | $371.63 | $355.91 | -4.2% | Buy | 12.7x | 44 |
PGRThe Progressive Corporation | $135.8B | $233.18 | $223.23 | -4.3% | Hold | 12.7x | 42 |
CINFCincinnati Financial Corporation | $28.9B | $188.31 | $198.00 | +5.1% | Hold | 21.0x | 17 |
UFGUni-Fuels Holdings Limited | $10M | $3.13 | — | — | — | — | — |
RNRRenaissanceRe Holdings Ltd. | $14.7B | $354.23 | $335.25 | -5.4% | Hold | 7.3x | 28 |
Quick answers to the most common questions about buying AII stock.
Wall Street's consensus price target for AII is $26.5, -2.1% from its current price of $27.08. The below-market target from 5 analysts suggests limited near-term appreciation.
AII has a consensus rating of "Buy" based on 5 Wall Street analysts. The rating breakdown is predominantly bullish, with 5 Buy/Strong Buy ratings. The consensus 12-month price target of $26.5 implies -2.1% downside from current levels.
With a forward P/E of 6.2928x, AII trades at a relatively low valuation. The consensus target of $26.5 implies -2.1% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $27 for AII, while the most conservative target is $26. The consensus of $26.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $47 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
AII is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month AII stock forecast based on 5 Wall Street analysts shows a consensus price target of $26.5, with estimates ranging from $26 (bear case) to $27 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $35, with bear/bull scenarios of $22/$47.
Our quantitative valuation model calculates AII's fair value at $35 (base case), with a bear case of $22 and bull case of $47. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 55/100.
AII trades at a forward P/E ratio of 6.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 4.8x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on AII, with 0 Sell ratings and a price target of $26.5 (-2.1% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
AII analyst price targets range from $26 to $27, a 4% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $26.5 consensus represents the middle ground. Our model's $22-$47 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.